Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Lebel

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|January 11, 1991
Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram bindingF J Vinick, N A Saccomano, B K Koe, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
Journal of Medicinal Chemistry|August 1, 1990
3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indoleJ E Macor, C A Burkhart, J H Heym, et al.
Journal of Medicinal Chemistry|February 1, 1991
Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesteraseJ A Lowe, R L Archer, D S Chapin, et al.
Neuropharmacology|December 13, 2006
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aidH Rollema, L K Chambers, J W Coe, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophreniaC J Schmidt, D S Chapin, J Cianfrogna, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|January 11, 1991
Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram bindingF J Vinick, N A Saccomano, B K Koe, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
Journal of Medicinal Chemistry|August 1, 1990
3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indoleJ E Macor, C A Burkhart, J H Heym, et al.
Journal of Medicinal Chemistry|February 1, 1991
Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesteraseJ A Lowe, R L Archer, D S Chapin, et al.
Neuropharmacology|December 13, 2006
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aidH Rollema, L K Chambers, J W Coe, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophreniaC J Schmidt, D S Chapin, J Cianfrogna, et al.
Pageof 2